Skip to Content

510 Results Found

  • Article
  • Open Access
18 Citations
5,998 Views
15 Pages

IFN-γ Induces PD-L1 Expression in Primed Human Basophils

  • Srinivasa Reddy Bonam,
  • Camille Chauvin,
  • Mano J. Mathew and
  • Jagadeesh Bayry

25 February 2022

Programmed death-ligand 1 (PD-L1) plays a key role in maintaining immune tolerance and also in immune evasion of cancers and pathogens. Though the identity of stimuli that induce PD-L1 in various human innate cells and their function are relatively w...

(This article belongs to the Special Issue Immunomodulatory Factors in Host Defense)
  • Article
  • Open Access
12 Citations
4,930 Views
13 Pages

Antitumor Effect of Korean Red Ginseng through Blockade of PD-1/PD-L1 Interaction in a Humanized PD-L1 Knock-In MC38 Cancer Mouse Model

  • Eun-Ji Lee,
  • Ju-Hye Yang,
  • Hye Jin Yang,
  • Chong-Kwan Cho and ,
  • Jang-Gi Choi and
  • Hwan-Suck Chung
  • + 1 author+ 0 author

18 January 2023

Blocking immune checkpoints, programmed death-1 (PD-1) and its ligand PD-L1, has proven a promising anticancer strategy for enhancing cytotoxic T cell activity. Although we previously demonstrated that ginsenoside Rg3, Rh2, and compound K block the i...

(This article belongs to the Special Issue Natural Products and Phytochemicals in Preventing and Treating Cancers)
  • Article
  • Open Access
57 Citations
14,262 Views
13 Pages

Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice

  • Eva-Maria Rom-Jurek,
  • Nicole Kirchhammer,
  • Peter Ugocsai,
  • Olaf Ortmann and ,
  • Anja K. Wege and
  • Gero Brockhoff
  • + 1 author+ 0 author

13 February 2018

Programmed death ligand 1 (PD-L1) expression is an efficient strategy of tumor cells to escape immunological eradiation. However, only little is known about the factors that affect the cellular expression levels. Here we assessed the PD-L1 expression...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
55 Citations
6,118 Views
19 Pages

A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-like Properties and Invasion in Human Bladder Cancer

  • Junlan Zhu,
  • Yang Li,
  • Yisi Luo,
  • Jiheng Xu and ,
  • Huating Liufu,
  • Zhongxian Tian,
  • Chao Huang,
  • Jingxia Li and
  • Chuanshu Huang
  • + 4 authors+ 0 author

12 March 2019

Programmed cell death protein 1 (PD-1) and its ligand PD-L1 blockade have been identified to target immune checkpoints to treat human cancers with durable clinical benefit. Several studies reveal that the response to PD-1-PD-L1 blockade might correla...

(This article belongs to the Special Issue Fox Proteins and Cancers: Old Proteins with Emerging New Tales)
  • Article
  • Open Access
33 Citations
3,311 Views
15 Pages

Regulation of Autophagic Signaling by Mechanical Loading and Inflammation in Human PDL Fibroblasts

  • Kim Blawat,
  • Alexandra Mayr,
  • Miriam Hardt,
  • Christian Kirschneck and ,
  • Marjan Nokhbehsaim,
  • Christian Behl,
  • James Deschner,
  • Andreas Jäger and
  • Svenja Memmert
  • + 4 authors+ 0 author

11 December 2020

Autophagy (cellular self-consumption) is a crucial adaptation mechanism during cellular stress conditions. This study aimed to examine how this important process is regulated in human periodontal ligament (PDL) fibroblasts by mechanical and inflammat...

(This article belongs to the Special Issue Oral Inflammation—Environment, Molecules, and Cells in Oral Physiology and Pathology)
  • Article
  • Open Access
57 Citations
6,994 Views
14 Pages

siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model

  • Jae Yun Jung,
  • Hyun Jin Ryu,
  • Seung-Hwan Lee,
  • Dong-Young Kim and ,
  • Myung Ji Kim,
  • Eun Ji Lee,
  • Yeon-Mi Ryu,
  • Sang-Yeob Kim,
  • Kyu-Pyo Kim and
  • Suhwan Chang
  • + 7 authors+ 2 authors

13 October 2021

Pancreatic cancer is characterized by late detection, frequent drug resistance, and a highly metastatic nature, leading to poor prognosis. Antibody-based immunotherapy showed limited success for pancreatic cancer, partly owing to the low delivery rat...

(This article belongs to the Special Issue Molecular Mechanisms and Therapeutic Modulation of Tumor Immune Microenvironment)
  • Feature Paper
  • Article
  • Open Access
17 Citations
6,651 Views
18 Pages

Human Keratinocytes Inhibit CD4+ T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints

  • Guillaume Mestrallet,
  • Frédéric Auvré,
  • Chantal Schenowitz,
  • Edgardo D. Carosella and ,
  • Joel LeMaoult,
  • Michèle T. Martin,
  • Nathalie Rouas-Freiss and
  • Nicolas O. Fortunel
  • + 3 authors+ 0 author

8 June 2021

Human skin protects the body against infection and injury. This protection involves immune and epithelial cells, but their interactions remain largely unknown. Here, we show that cultured epidermal keratinocytes inhibit allogenic CD4+ T-cell prolifer...

(This article belongs to the Collection Molecular Determinants of Skin Integrity)
  • Article
  • Open Access
2 Citations
2,767 Views
20 Pages

The periodontal ligament (PDL) is a highly specialized fibrous tissue comprising heterogeneous cell populations of an intricate nature. These complexities, along with challenges due to cell culture, impede a comprehensive understanding of periodontal...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Case Report
  • Open Access
3 Citations
1,999 Views
8 Pages

Mixed Infectious–Immune Pneumonitis Associated with PD-L1 Blockade: A Case of Durvalumab-Induced Lung Injury Complicated by Human Metapneumovirus Infection

  • Luca Pipitò,
  • Chiara Vincenza Mazzola,
  • Ilenia Giacchino,
  • Riccardo De Rosa and ,
  • Carola Maria Gagliardo,
  • Alessio Giuseppe Lipari,
  • Paola Monte,
  • Federica Furia,
  • Erika Mannino and
  • Antonio Cascio
  • + 7 authors+ 2 authors

29 December 2025

Background: Durvalumab, a PD-L1 inhibitor used as consolidation therapy after chemoradiation in unresectable stage III non–small cell lung cancer (NSCLC), can induce immune-related adverse events, among which immune-mediated pneumonitis represe...

(This article belongs to the Section Infectious Diseases)
  • Article
  • Open Access
22 Citations
5,380 Views
19 Pages

Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion

  • Christina Bruss,
  • Kerstin Kellner,
  • Veruschka Albert,
  • James A. Hutchinson and ,
  • Stephan Seitz,
  • Olaf Ortmann,
  • Gero Brockhoff and
  • Anja K. Wege
  • + 3 authors+ 0 author

4 May 2023

Checkpoint blockade is particularly based on PD-1/PD-L1-inhibiting antibodies. However, an efficient immunological tumor defense can be blocked not only by PD-(L)1 but also by the presence of additional immune checkpoint molecules. Here, we investiga...

(This article belongs to the Special Issue Checkpoint Markers and Cancer Microenvironment: What Do We Know?)
  • Article
  • Open Access
10 Citations
3,353 Views
11 Pages

CD8+ T Cells and PD-L1 Expression as Prognostic Indicators in a Low Prevalence of HPV-Associated Oropharyngeal Squamous Cell Carcinoma

  • Kawita Atipas,
  • Natthawadee Laokulrath,
  • Janjira Petsuksiri,
  • Narin Ratanaprasert and
  • Warut Pongsapich

20 January 2023

Human papillomavirus (HPV) infection detected in oropharyngeal squamous cell carcinoma (OPSCC) is associated with a better survival outcome from previous literature. However, Thailand and several Asian countries have a low prevalence of HPV-associate...

(This article belongs to the Special Issue New Frontiers in Head and Neck Oncology)
  • Article
  • Open Access
1,627 Views
13 Pages

24 February 2026

Background: Cervical cancer is the second most prevalent malignancy among South African women, with high-risk human papillomavirus (HPV) infection as a critical risk factor. HPV plays a central role in cervical carcinogenesis, particularly in high-gr...

  • Article
  • Open Access
9 Citations
5,775 Views
17 Pages

HER2 and PD-L1 Expression in Gastric and Gastroesophageal Junction Cancer: Insights for Combinatorial Targeting Approaches

  • Marta Baptista Freitas,
  • Irene Gullo,
  • Dina Leitão,
  • Lúcia Águas and ,
  • Carla Oliveira,
  • António Polónia,
  • Joana Gomes,
  • Fátima Carneiro,
  • Celso Albuquerque Reis and
  • Henrique Oliveira Duarte
  • + 5 authors+ 0 author

20 March 2024

Gastric and gastroesophageal junction adenocarcinomas (GA/GEJA) are associated with a poor prognosis, primarily due to late disease diagnosis. Human Epidermal Growth Factor Receptor 2 (HER2) overexpression and programmed death-ligand 1 (PD-L1) expres...

(This article belongs to the Special Issue Developments in the Management of Gastrointestinal Malignancies)
  • Article
  • Open Access
34 Citations
3,955 Views
12 Pages

Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma

  • Anja Wessely,
  • Markus V. Heppt,
  • Claudia Kammerbauer,
  • Theresa Steeb and ,
  • Thomas Kirchner,
  • Michael J. Flaig,
  • Lars E. French,
  • Carola Berking,
  • Elisa Schmoeckel and
  • Markus Reinholz
  • + 5 authors+ 0 author

4 September 2020

Anal squamous cell carcinoma (SCC) is a rare cancer with increasing incidence. Infection with high-risk human papillomavirus (HPV) subtypes is the major cause for its development. We retrospectively analyzed tumor samples from 54 anal SCC patients fo...

  • Review
  • Open Access
16 Citations
4,996 Views
27 Pages

25 June 2021

While head and neck squamous cell carcinomas (HNSCC) are marginally decreasing due to the reduction in exposure to the major risk factors, tobacco and alcohol, the incidence of high-risk human papillomavirus (HPV)-positive oropharynx squamous cell ca...

(This article belongs to the Special Issue HPV in the Head and Neck Region)
  • Article
  • Open Access
67 Citations
9,913 Views
19 Pages

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

  • Katrijn Broos,
  • Quentin Lecocq,
  • Catarina Xavier,
  • Jessica Bridoux and ,
  • Tham T. Nguyen,
  • Jurgen Corthals,
  • Steve Schoonooghe,
  • Eva Lion,
  • Geert Raes and
  • Karine Breckpot
  • + 7 authors+ 2 authors

21 June 2019

The PD-1:PD-L1 immune checkpoint axis is central in the escape of cancer cells from anticancer immune responses. Monoclonal antibodies (mAbs) specific for PD-L1 have been approved for treatment of various cancer types. Although PD-L1 blockade has pro...

  • Article
  • Open Access
1 Citations
1,082 Views
22 Pages

Expression of PD-L1 and PD-L2 and Their Association with IFN-γ/STAT1/STAT3 Signaling in Human Clear Cell Renal Cell Carcinoma (ccRCC)

  • Gábor Kónya,
  • Ali Shammas,
  • Erzsébet Szabó,
  • Róbert Tupicza and ,
  • Seyed Behrad Piran,
  • Krisztián Szegedi,
  • Anna Vass,
  • Éva Juhász,
  • József Király and
  • Gábor Halmos
  • + 8 authors+ 3 authors

5 June 2026

Background: Programmed cell death protein-1 (PD-1) and its ligands, PD-L1 and PD-L2, constitute a central immune checkpoint pathway that regulates T-cell activity and tumor immune escape, while their relationship with STAT signaling remains incomplet...

(This article belongs to the Special Issue Advances in Diagnosis and Treatment of Urological Cancers)
  • Review
  • Open Access
470 Views
25 Pages

9 September 2026

Persistent infection with high-risk human papillomavirus (hrHPV) is the principal cause of cervical cancer and initiates a complex process of immune evasion that enables malignant progression despite continuous expression of the viral oncoproteins E6...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
12 Citations
3,805 Views
14 Pages

IL-27 Mediates PD-L1 Expression and Release by Human Mesothelioma Cells

  • Grazia Carbotti,
  • Beatrice Dozin,
  • Stefania Martini,
  • Chiara Giordano and ,
  • Francesca Scordamaglia,
  • Michela Croce,
  • Gilberto Filaci,
  • Silvano Ferrini and
  • Marina Fabbi
  • + 4 authors+ 0 author

9 August 2021

Malignant mesothelioma (MM) is a rare tumor with an unfavorable prognosis. MM genesis involves asbestos-mediated local inflammation, supported by several cytokines, including IL-6. Recent data showed that targeting PD-1/PD-L1 is an effective therapy...

  • Article
  • Open Access
12 Citations
3,786 Views
16 Pages

Moesin Serves as Scaffold Protein for PD-L1 in Human Uterine Cervical Squamous Carcinoma Cells

  • Rina Doukuni,
  • Takuro Kobori,
  • Chihiro Tanaka,
  • Mayuka Tameishi and ,
  • Yoko Urashima,
  • Takuya Ito and
  • Tokio Obata
  • + 2 authors+ 0 author

1 July 2022

Immune checkpoint blockade (ICB) therapy targeting the programmed death ligand-1 (PD-L1)/PD-1 axis has emerged as a promising treatment for uterine cervical cancer; however, only a small subset of patients with uterine cervical squamous cell carcinom...

(This article belongs to the Section Obstetrics & Gynecology)
  • Article
  • Open Access
17 Citations
4,917 Views
29 Pages

Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes

  • Nofar Erlichman,
  • Tamir Baram,
  • Tsipi Meshel,
  • Dina Morein and ,
  • Benny Da’adoosh and
  • Adit Ben-Baruch
  • + 1 author+ 0 author

18 February 2022

Therapies targeting the PD-L1/PD-1 axis have recently been introduced to triple-negative breast cancer (TNBC) with limited efficacy, suggesting that this axis promotes tumor progression through mechanisms other than immune suppression. Here, we over-...

(This article belongs to the Special Issue Emerging Roles of Chemokines in Cancer Immunotherapy)
  • Article
  • Open Access
17 Citations
4,977 Views
28 Pages

19 July 2022

Pro-inflammatory cytokines play key roles in elevating cancer progression in triple-negative breast cancer (TNBC). We demonstrate that specific combinations between TNFα, IL-1β and IFNγ up-regulated the proportion of human TNBC cells...

(This article belongs to the Special Issue Immunotherapy of Triple-Negative Breast Cancer)
  • Article
  • Open Access
12 Citations
3,851 Views
17 Pages

Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells

  • Thuzar Hla Shwe,
  • Peraphan Pothacharoen,
  • Thanyaluck Phitak,
  • Benjawan Wudtiwai and
  • Prachya Kongtawelert

15 August 2021

Liver cancer is the sixth most common cancer worldwide with high morbidity and mortality. Programmed death ligand 1 (PD-L1) is a major ligand of programmed death 1 receptor (PD1), and PD1/PD-L1 checkpoint acts as a negative regulator of the immune sy...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
9 Citations
4,420 Views
15 Pages

Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model

  • Marisa Capitao,
  • Justine Perrin,
  • Sylvain Simon,
  • Sébastien Gouard and ,
  • Nicolas Chouin,
  • Frank Bruchertseifer,
  • Alfred Morgenstern,
  • Latifa Rbah-Vidal,
  • Michel Chérel and
  • Joëlle Gaschet
  • + 8 authors+ 3 authors

12 March 2021

PD-L1 (programmed death-ligand 1, B7-H1, CD274), the ligand for PD-1 inhibitory receptor, is expressed on various tumors, and its expression is correlated with a poor prognosis in melanoma. Anti-PD-L1 mAbs have been developed along with anti-CTLA-4 a...

(This article belongs to the Special Issue Recent Developments of Nuclear Medicine in Cancer Diagnosis and Theranostics)
  • Article
  • Open Access
30 Citations
6,241 Views
11 Pages

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry

  • Dora Mugoli Chigoho,
  • Quentin Lecocq,
  • Robin Maximilian Awad,
  • Karine Breckpot and ,
  • Nick Devoogdt,
  • Marleen Keyaerts,
  • Vicky Caveliers,
  • Catarina Xavier and
  • Jessica Bridoux
  • + 4 authors+ 0 author

Immune checkpoint inhibitors targeting the programmed cell death-1 (PD-1) and its ligand PD-L1 have proven to be efficient cancer therapies in a subset of patients. From all the patients with various cancer types, only 20% have a positive response. B...

(This article belongs to the Section Medicinal Chemistry)
  • Review
  • Open Access
16 Citations
3,937 Views
8 Pages

The immune system has evolved as a complex and efficient means of coping with extrinsic materials, such as pathogens and toxins, as well as intrinsic abnormalities, such as cancers. Although rapid and timely activation of the immune system is obvious...

(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
  • Article
  • Open Access
20 Citations
4,137 Views
14 Pages

Nicotinic Acetylcholine Receptor Subunit α7 Mediates Cigarette Smoke-Induced PD-L1 Expression in Human Bronchial Epithelial Cells

  • Hoi-Hin Kwok,
  • Boning Gao,
  • Koon-Ho Chan,
  • Mary Sau-Man Ip and ,
  • John Dorrance Minna and
  • David Chi-Leung Lam
  • + 1 author+ 0 author

25 October 2021

Tobacco smoking is the top risk factor for lung cancer development. Nicotine in cigarettes can induce addiction, and its derivatives become potent carcinogens after metabolic activation and activate oncogenic signaling in lung epithelial cells throug...

(This article belongs to the Special Issue Molecular Mechanisms of Lung Cancer and Mesothelioma)
  • Article
  • Open Access
7 Citations
4,610 Views
15 Pages

14 September 2022

Immune checkpoint inhibitors (ICIs) have been shown to be extraordinarily effective in patients with colorectal cancer (CRC). However, the current ICIs still have adverse effects and limited efficacy of ICI monotherapy. We used a natural product to o...

(This article belongs to the Special Issue Recent Advances in Cancer Therapy)
  • Article
  • Open Access
19 Citations
6,208 Views
17 Pages

25 June 2020

Immune checkpoint inhibitors (ICIs) are yet to have a major advantage over conventional therapies, as only a fraction of patients benefit from the currently approved ICIs and their response rates remain low. We investigated the effects of different I...

(This article belongs to the Section Human Genomics and Genetic Diseases)
  • Article
  • Open Access
1 Citations
1,362 Views
20 Pages

Identification and Characterization of SRSF2 as a Splicing-Relevant Factor Associated with the Distribution of Membranous to Secreted PD-L1, Exemplarily Considered on Human Renal Tissue, Including Renal Cell Carcinoma

  • Tim Hohmann,
  • Urszula Hohmann,
  • Faramarz Dehghani,
  • Hendrik Borgmann and ,
  • Olaf Grisk,
  • Galyna Pryymachuk and
  • Simon Jasinski-Bergner
  • + 2 authors+ 0 author

28 October 2025

Background: The immunomodulatory molecule PD-L1 and its immunological tolerance-mediating interaction with the PD-1 receptor on many immune effector cells represent one of the most important tumor immune checkpoint axes in antibody-based anti-tumor t...

(This article belongs to the Special Issue Communication and Accessibility in the Tumor Microenvironment as a Therapeutic Target)
  • Article
  • Open Access
788 Views
14 Pages

Cinnamon-Derived Compounds Reduce PD-L1 Expression in UV-Exposed Human Skin Cell Line

  • Chidambaram Ramanathan,
  • Richard J. Bloomer and
  • Gus Romero

Background/Objective: Ultraviolet A and B (UVAB) radiation is a major environmental factor that induces DNA damage and upregulates programmed death-ligand 1 (PD-L1) expression in skin cells, thereby contributing to immune evasion and impaired tissue...

  • Feature Paper
  • Article
  • Open Access
71 Citations
7,983 Views
15 Pages

Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation

  • Jessica Bridoux,
  • Katrijn Broos,
  • Quentin Lecocq,
  • Pieterjan Debie and ,
  • Charlotte Martin,
  • Steven Ballet,
  • Geert Raes,
  • Sara Neyt,
  • Christian Vanhove and
  • Catarina Xavier
  • + 9 authors+ 4 authors

29 September 2020

Immune checkpoints, such as programmed death-ligand 1 (PD-L1), limit T-cell function and tumor cells use this ligand to escape the anti-tumor immune response. Treatments with monoclonal antibodies blocking these checkpoints have shown long-lasting re...

(This article belongs to the Special Issue The Therapeutic and Diagnostic Potential of Nanobodies)
  • Article
  • Open Access
60 Citations
11,668 Views
17 Pages

25 July 2019

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, which shows resistance to common breast cancer therapies, as it lacks the expression of the most common breast cancer targets. Therefore, TNBC treatment remains a chal...

  • Article
  • Open Access
16 Citations
4,511 Views
24 Pages

A Novel Oncogenic Role of FDX1 in Human Melanoma Related to PD-L1 Immune Checkpoint

  • Huijiao Lu,
  • Jiahua Liang,
  • Xue He,
  • Huabin Ye and ,
  • Chuangdong Ruan,
  • Hongwei Shao,
  • Rongxin Zhang and
  • Yan Li
  • + 3 authors+ 0 author

The aim of this study was to evaluate the association between Ferredoxin 1 (FDX1) expression and the prognostic survival of tumor patients and predict the efficacy of immunotherapy response to antitumor drug sensitivity. FDX1 plays an oncogenic role...

(This article belongs to the Special Issue Immunophenotyping in Autoimmune Diseases and Cancer, 3rd Edition)
  • Study Protocol
  • Open Access
4 Citations
2,769 Views
14 Pages

The Prognostic and Predictive Value of Human Gastrointestinal Microbiome and Exosomal mRNA Expression of PD-L1 and IFNγ for Immune Checkpoint Inhibitors Response in Metastatic Melanoma Patients: PROTOCOL TRIAL

  • Ana Erman,
  • Marija Ignjatović,
  • Katja Leskovšek,
  • Simona Miceska and ,
  • Urša Lampreht Tratar,
  • Maša Bošnjak,
  • Veronika Kloboves Prevodnik,
  • Maja Čemažar,
  • Lidija Kandolf Sekulovič and
  • Tanja Mesti
  • + 7 authors+ 2 authors

Background: Immunotherapy has been successful in treating advanced melanoma, but a large proportion of patients do not respond to the treatment with immune checkpoint inhibitors (ICIs). Preclinical and small cohort studies suggest gastrointestinal mi...

(This article belongs to the Section Cancer Biology and Oncology)
  • Article
  • Open Access
26 Citations
5,541 Views
13 Pages

Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production

  • Katrijn Broos,
  • Quentin Lecocq,
  • Brenda De Keersmaecker,
  • Geert Raes and ,
  • Jurgen Corthals,
  • Eva Lion,
  • Kris Thielemans,
  • Nick Devoogdt,
  • Marleen Keyaerts and
  • Karine Breckpot
  • + 5 authors+ 0 author

Dendritic cell [DC] vaccines can induce durable clinical responses, at least in a fraction of previously treated, late stage cancer patients. Several preclinical studies suggest that shielding programmed death-ligand 1 [PD-L1] on the DC surface may b...

(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)
  • Article
  • Open Access
59 Citations
6,080 Views
20 Pages

Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro

  • Woan Ting Tay,
  • Yi-Hsien Fang,
  • Suet Theng Beh,
  • Yen-Wen Liu and ,
  • Ling-Wei Hsu,
  • Chia-Jui Yen and
  • Ping-Yen Liu
  • + 2 authors+ 0 author

Aim: Immunological checkpoint therapy is considered a powerful method for cancer therapy and acts by re-activating autologous T cells to kill the cancer cell. Myocarditis cases have been reported in cancer patients after immunological therapy; for ex...

(This article belongs to the Section Biochemistry)
  • Communication
  • Open Access
22 Citations
3,858 Views
12 Pages

Gated Resonance Energy Transfer (gRET) Controlled by Programmed Death Protein Ligand 1

  • Hubert Grel,
  • Katarzyna Ratajczak,
  • Slawomir Jakiela and
  • Magdalena Stobiecka

13 August 2020

The resonance energy transfer (RET) between an excited fluorescent probe molecule and a plasmonic nanoparticle (AuNP) has been investigated to evaluate the effect of protein molecules on the RET efficiency. We have found that the energy transfer to a...

(This article belongs to the Special Issue Gold Nanoparticle-Based Biosensors)
  • Article
  • Open Access
14 Citations
4,458 Views
16 Pages

Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma

  • W. Quinn O’Neill,
  • Xiujie Xie,
  • Shanying Gui,
  • Heping Yu and ,
  • Jacqueline Davenport,
  • Thomas Cartwright,
  • Marta Storl-Desmond,
  • Esther Ryu,
  • Ernest R. Chan and
  • Quintin Pan
  • + 8 authors+ 3 authors

7 January 2022

Human papillomavirus-associated head and neck squamous cell carcinoma (HPV+ HNSCC) is recognized as a distinct disease with unique etiology and clinical features. Current standard of care therapeutic modalities are identical for HPV+ and HPV− H...

(This article belongs to the Special Issue Human Papillomavirus (HPV) Associated Head and Neck Cancers: From Basic Biology to Clinical Challenges)
  • Article
  • Open Access
23 Citations
5,090 Views
18 Pages

Mechanical Compression by Simulating Orthodontic Tooth Movement in an In Vitro Model Modulates Phosphorylation of AKT and MAPKs via TLR4 in Human Periodontal Ligament Cells

  • Charlotte E. Roth,
  • Rogerio B. Craveiro,
  • Christian Niederau,
  • Hanna Malyaran and ,
  • Sabine Neuss,
  • Joachim Jankowski and
  • Michael Wolf
  • + 2 authors+ 0 author

Mechanical compression simulating orthodontic tooth movement in in vitro models induces pro-inflammatory cytokine expression in periodontal ligament (PDL) cells. Our previous work shows that TLR4 is involved in this process. Here, primary PDL cells a...

(This article belongs to the Special Issue The Role of Toll-Like Receptors (TLR) in Infection and Inflammation)
  • Article
  • Open Access
14 Citations
4,946 Views
16 Pages

Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities

  • Anne Menz,
  • Julia Zerneke,
  • Florian Viehweger,
  • Seyma Büyücek and ,
  • David Dum,
  • Ria Schlichter,
  • Andrea Hinsch,
  • Ahmed Abdulwahab Bawahab,
  • Christoph Fraune and
  • Till Krech
  • + 24 authors+ 19 authors

30 June 2024

Stimulator of interferon genes protein (STING) activates the immune response in inflammatory cells. STING expression in cancer cells is less well characterized, but STING agonists are currently being evaluated as anticancer drugs. A tissue microarray...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
3 Citations
2,642 Views
14 Pages

Release of Exosomal PD-L1 in Bone and Soft Tissue Sarcomas and Its Relationship to Radiotherapy

  • Keisuke Yoshida,
  • Kunihiro Asanuma,
  • Yumi Matsuyama,
  • Takayuki Okamoto and ,
  • Tomohito Hagi,
  • Tomoki Nakamura and
  • Akihiro Sudo
  • + 2 authors+ 0 author

8 July 2024

(1) Background: Exosomal PD-L1 has garnered attention owing to its role in instigating systemic immune suppression. The objective of this study is to elucidate whether bone and soft tissue sarcoma cells possess the capacity to secrete functionally ac...

(This article belongs to the Special Issue Combination Immunotherapy for Cancer Treatment)
  • Article
  • Open Access
37 Citations
6,382 Views
16 Pages

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

  • Behrus Puladi,
  • Mark Ooms,
  • Svetlana Kintsler,
  • Khosrow Siamak Houschyar and ,
  • Florian Steib,
  • Ali Modabber,
  • Frank Hölzle,
  • Ruth Knüchel-Clarke and
  • Till Braunschweig
  • + 4 authors+ 0 author

31 August 2021

Immune checkpoint inhibitors (ICI) represent a new therapeutic approach in recurrent and metastatic head and neck squamous cell carcinoma (HNSCC). The patient selection for the PD-1/PD-L1 inhibitor therapy is based on the degree of PD-L1 expression i...

(This article belongs to the Collection Artificial Intelligence in Oncology)
  • Article
  • Open Access
12 Citations
5,660 Views
14 Pages

Construction of Human Periodontal Ligament Constitutive Model Based on Collagen Fiber Content

  • Bin Wu,
  • Na Li,
  • Mao Liu,
  • Ke Cheng and ,
  • Di Jiang,
  • Yang Yi,
  • Songyun Ma,
  • Bin Yan and
  • Yi Lu
  • + 4 authors+ 0 author

6 October 2023

Periodontal ligament (PDL) is mainly composed of collagen fiber bundles, and the content of collagen fiber is an important factor affecting the mechanical properties of PDL. Based on this, the purpose of this study is to explore the effect of the PDL...

  • Article
  • Open Access
4 Citations
3,625 Views
13 Pages

Formulation of Hyperelastic Constitutive Model for Human Periodontal Ligament Based on Fiber Volume Fraction

  • Bin Wu,
  • Chenfeng Huang,
  • Na Li,
  • Yi Lu and ,
  • Yang Yi,
  • Bin Yan and
  • Di Jiang
  • + 2 authors+ 0 author

6 February 2025

Collagen fibers of the Periodontal ligament (PDL) play a crucial role in determining its mechanical properties. Based on this premise, we investigated the effect of the volume fraction of human PDL collagen fibers on the hyperelastic mechanical behav...

  • Review
  • Open Access
34 Citations
9,457 Views
10 Pages

The programmed death-ligand 1(PD-L1)/PD-1 pathway is an immunological checkpoint in cancer cells. The binding of PD-L1 and PD-1 promotes T-cell tolerance and helps tumor cells escape from host immunity. Immunotherapy targeting the PD-L1/PD-1 axis has...

(This article belongs to the Section Immunology and Immunotherapy)
  • Communication
  • Open Access
9 Citations
3,044 Views
10 Pages

8 December 2020

Specific orientations of periodontal ligaments (PDLs) to tooth-root surface play an important role in offering positional stabilities of teeth, transmitting and absorbing various stresses under masticatory/occlusal loading conditions, or promoting ti...

(This article belongs to the Special Issue Optimization of Biomaterials for Reconstructive and Regenerative Medicine)
  • Article
  • Open Access
20 Citations
4,854 Views
13 Pages

NDRG2 Expression in Breast Cancer Cells Downregulates PD-L1 Expression and Restores T Cell Proliferation in Tumor-Coculture

  • Aram Lee,
  • Soyoung Lim,
  • Juyeong Oh,
  • Jihyun Lim and ,
  • Young Yang,
  • Myeong-Sok Lee and
  • Jong-Seok Lim
  • + 2 authors+ 0 author

4 December 2021

(1) Background: The aim of the present study was to evaluate the effect of NDRG2 expression in regulating PD-L1 or PD-L2 on malignant breast cancer cells. (2) Methods: Overexpression and knockdown of the NDRG2 gene in human and mouse cancer cells wer...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
7 Citations
4,865 Views
20 Pages

PAX9 Is Involved in Periodontal Ligament Stem Cell-like Differentiation of Human-Induced Pluripotent Stem Cells by Regulating Extracellular Matrix

  • Risa Sugiura,
  • Sayuri Hamano,
  • Atsushi Tomokiyo,
  • Daigaku Hasegawa and ,
  • Shinichiro Yoshida,
  • Hideki Sugii,
  • Shoko Fujino,
  • Orie Adachi,
  • Masataka Kadowaki and
  • Hidefumi Maeda
  • + 6 authors+ 1 author

22 September 2022

Periodontal ligament stem cells (PDLSCs) play central roles in periodontal ligament (PDL) tissue homeostasis, repair, and regeneration. Previously, we established a protocol to differentiate human-induced pluripotent stem cell-derived neural crest-li...

(This article belongs to the Special Issue Cell Biology in Dentistry)
  • Article
  • Open Access
29 Citations
4,117 Views
13 Pages

Adipose-Tissue-Derived Mesenchymal Stem Cells Mediate PD-L1 Overexpression in the White Adipose Tissue of Obese Individuals, Resulting in T Cell Dysfunction

  • Assia Eljaafari,
  • Julien Pestel,
  • Brigitte Le Magueresse-Battistoni,
  • Stephanie Chanon and ,
  • Julia Watson,
  • Maud Robert,
  • Emmanuel Disse and
  • Hubert Vidal
  • + 3 authors+ 0 author

3 October 2021

The PD-L1/PD-1 immune checkpoint axis is the strongest T cell exhaustion inducer. As immune dysfunction occurs during obesity, we analyzed the impact of obesity on PD-L1/PD-1 expression in white adipose tissue (WAT) in mice and in human white adipocy...

(This article belongs to the Collection Cellular Immunology and COVID-19)

of 11